Klotho Neurosciences Files Proxy Statement for May 28 Meeting

Ticker: GRMLW · Form: DEF 14A · Filed: May 5, 2025 · CIK: 1907223

Sentiment: neutral

Topics: proxy-statement, annual-meeting, corporate-governance

TL;DR

Klotho Neurosciences (KLTH) proxy filed. Annual meeting May 28. Vote your shares!

AI Summary

Klotho Neurosciences, Inc. filed its definitive proxy statement on May 5, 2025, for its annual meeting on May 28, 2025. The company, formerly known as Redwoods Acquisition Corp. and ANEW Medical, Inc., is in the biological products sector. The filing details information for shareholders regarding the upcoming meeting and company matters.

Why It Matters

This filing provides shareholders with essential information to exercise their voting rights at the upcoming annual meeting, impacting corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently introduce new financial risks.

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with a proxy statement for the annual meeting of Klotho Neurosciences, Inc., scheduled for May 28, 2025.

When was this proxy statement filed with the SEC?

This proxy statement was filed with the SEC on May 5, 2025.

What were Klotho Neurosciences, Inc.'s former company names?

Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. (name change effective June 24, 2024) and Redwoods Acquisition Corp. (name change effective January 27, 2022).

What is the business address of Klotho Neurosciences, Inc.?

The business address of Klotho Neurosciences, Inc. is 1115 Broadway, 12th Floor, New York, NY 10010.

What is the Standard Industrial Classification (SIC) code for Klotho Neurosciences, Inc.?

The Standard Industrial Classification (SIC) code for Klotho Neurosciences, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 5, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing